Company intelligence / Profile preview
PARI Pharma
Starnberg, Bavaria, Germanypari.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
PARI Pharma develops and commercializes advanced inhalation devices and partners with pharmaceutical companies to deliver both proprietary and partner drugs via its eFlow vibrating membrane nebulizer platform. The company’s focus on optimizing drug-device combinations has led to improved therapeutic efficiency for several respiratory diseases. Clinical results are not detailed in public sources but the company’s products are widely used globally in both clinical practice and at home settings
- Therapeutic areas
- Pulmonology
- Modalities
- DeviceSmall moleculeBiologic
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Collaborates with pharmaceutical industry partners
Beyond the preview
Go deeper on PARI Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PARI Pharma.